Douwe F. Postma - Concepedia

Author

Douwe F. Postma

University Medical Center Groningen ORCID

Also Known As

A. Middel, Andra-Maris Post, Cornelis H. van Werkhoven, D F Postma, D. F. Postma, D.F. Postma, Douwe F Postma, Douwe F. Postma, Douwe Postma, Lonneke Buitenhuis

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University Medical Center Groningen University Medical Center Utrecht Erasmus MC Amsterdam University Medical Centers University of Groningen

About

Douwe F. Postma is an author at University Medical Center Groningen specializing in medicine, vaccination, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	146
2	Immunology	4	4	67
3	Epidemiology	3	3	79
4	Public Health	1	1	31
5	Allergy	1	1	34

Douwe F. Postma

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Antibiotic Treatment Strategies for Community-Acquired Pneumonia in Adults Douwe F. Postma, Cornelis H. van Werkhoven, Leontine J. R. van Elden, New England Journal of Medicine	2015	376
Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands Marie‐Josée J. Mangen, Mark H. Rozenbaum, Susanne M. Huijts, European Respiratory Journal	2015	135
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming Roos S. G. Sablerolles, Wim J. R. Rietdijk, Abraham Goorhuis, New England Journal of Medicine	2022	125
Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP M. F. Engel, Douwe F. Postma, Marlies Hulscher, European Respiratory Journal	2012	66
Clinical Impact of Polymerase Chain Reaction–Based <i>Aspergillus</i> and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study Sammy Huygens, Albert Dunbar, Jochem B. Buil, Clinical Infectious Diseases	2023	52
Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial Douwe F. Postma, Cristian Spitoni, Cornelis H. van Werkhoven, BMC Infectious Diseases	2019	40
Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients A. J. J. Lammers, Richard M. Brohet, R.E.P. Theunissen, International Journal of Infectious Diseases	2020	40
Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial Eva L. Koekenbier, Konstantin Föhse, Josephine van de Maat, Clinical Microbiology and Infection	2023	39
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial Ngoc H. Tan, Daryl Geers, Roos S. G. Sablerolles, The Lancet Infectious Diseases VaccinationVaccine SafetyDirect Boost GroupPreventive MedicineAllergy	2023	34
Identification of patients at high risk for Clostridium difficile infection: development and validation of a risk prediction model in hospitalized patients treated with antibiotics Cornelis H. van Werkhoven, Jan van der Tempel, Rana Jajou, Clinical Microbiology and Infection Preventive MedicineAntibioticsClostridium Difficile InfectionDisease Risk AssessmentHealthcare-associated Infection	2015	31

Page 1